Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) SHH
38.88
+0.48(+1.25%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.71B |
| Enterprise Value | 12.89B |
| P/E Ratio | 12.95 |
| PEG Ratio | -3.12 |
| Price/Sales Ratio | 4.19 |
| Price/Book Ratio | 3.21 |
| Enterprise/Revenue | 3.6 |
| Enterprise/EBITDA | 10.73 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.32 |
| Operating Margin | 0.31 |
Management Effectiveness
| Return On Assets | 0.15 |
| Return On Equity | 0.25 |
Income Statement
| Revenue | 2.95B |
| Revenue/Share | 9.29 |
| Gross Profit | 2.74B |
| EBITDA | 1B |
| Net Income | 937.93M |
| Diluted EPS | 2.91 |
Balance Sheet
| Total Cash | 3.82B |
| Total Cash/Share | 11.86 |
| Total Debt | 1.06B |
| Total Debt/Equity | 0.27 |
| Current Ratio | 2.88 |
| Book Value Per Share | 13.12 |
Price History
| 52-Week Change | 2.91 |
| 52-Week High | 57.98 |
| 52-Week Low | 35.6 |
| Moving Average 50 Days | 41.01 |
| Moving Average 200 Days | 43.92 |
Statistics
| Average Volume | 3.39M |
| Shares Outstanding | 322.32M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.76 |
| Trailing Annual Dividend Yield | 4.52 |
| Payout Ratio | 0.88 |
| Last Split Factor | 13:10 |
| Last Split Date | April 30, 2024 |
